Henry Schein Inc. stock falls 1.40% amid broader market downturn

4 articles · Updated · MarketWatch · Apr 28

Shares closed at $76.12 on Tuesday, marking their third consecutive day of losses and trailing 14.75% below the 52-week high of $89.29.
Despite the decline, Henry Schein outperformed Stryker and IDEXX Laboratories, while McKesson posted a gain. Trading volume was 1.1 million, below the 50-day average.
The losses reflect a generally poor trading session for the market, with the S&P 500 and Dow Jones also declining. Henry Schein's performance remains mixed compared to sector peers.

With insiders selling shares, is Henry Schein's pivot to high-margin tech a major risk or a buying opportunity?

Analysts are divided on Henry Schein. Is the stock an undervalued gem or a value trap in a growing industry?

Are Henry Schein's AI investments enough to make it a leader in the $13.7 billion digital dentistry market?

As a new CEO takes charge, can Henry Schein overcome its slow growth to capture the booming dental market?

How will midterm election volatility and global tensions impact healthcare distribution stocks this year?